ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 115 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,636 | -32.2% | 16,646 | -26.3% | 0.00% | 0.0% |
| Q2 2023 | $36,346 | -52.3% | 22,575 | -14.2% | 0.00% | -50.0% |
| Q1 2023 | $76,261 | -15.0% | 26,297 | -3.9% | 0.00% | 0.0% |
| Q4 2022 | $89,708 | -22.0% | 27,350 | -9.8% | 0.00% | -33.3% |
| Q3 2022 | $115,000 | -57.1% | 30,314 | -11.8% | 0.00% | -50.0% |
| Q2 2022 | $268,000 | -20.0% | 34,364 | -4.6% | 0.01% | 0.0% |
| Q1 2022 | $335,000 | -39.4% | 36,015 | +2.6% | 0.01% | -40.0% |
| Q4 2021 | $553,000 | -11.5% | 35,106 | +0.5% | 0.01% | -16.7% |
| Q3 2021 | $625,000 | +107.6% | 34,938 | +80.5% | 0.01% | +140.0% |
| Q2 2021 | $301,000 | +11.5% | 19,354 | +3.0% | 0.01% | 0.0% |
| Q1 2021 | $270,000 | -24.2% | 18,784 | +3.5% | 0.01% | -37.5% |
| Q4 2020 | $356,000 | +61.1% | 18,149 | +6.3% | 0.01% | +33.3% |
| Q3 2020 | $221,000 | +23.5% | 17,078 | +34.7% | 0.01% | +20.0% |
| Q3 2019 | $179,000 | -11.8% | 12,682 | +25.2% | 0.01% | -16.7% |
| Q2 2019 | $203,000 | -42.0% | 10,132 | +15.2% | 0.01% | -33.3% |
| Q1 2019 | $350,000 | +33.6% | 8,792 | +16.5% | 0.01% | +12.5% |
| Q4 2018 | $262,000 | -16.8% | 7,545 | -0.9% | 0.01% | 0.0% |
| Q3 2018 | $315,000 | +12.5% | 7,612 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $280,000 | – | 7,612 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOR CAPITAL ADVISORS, INC. | 208,827 | $107,086 | 0.02% |